LinPH, AronsonW, FreedlandSJ. An update of research evidence on nutrition and prostate cancer. Urol Oncol, 2017; 37:387–401.
2.
AhernT, WuFC. New horizons in testosterone and the ageing male. Age Ageing, 2015; 44:188–195.
3.
LordC, SekerovicZ, CarrierJ. Sleep regulation and sex hormones exposure in men and women across adulthood. Pathol Biol (Paris), 2014; 62:302–310.
4.
KupchakBR, KraemerWJ, HoffmanMD, et al.The impact of an ultramarathon on hormonal and biochemical parameters in men. Wilderness Environ Med, 2014; 25:278–288.
5.
WittertG. The relationship between sleep disorders and testosterone in men. Asian J Androl, 2014; 16:262–265.
6.
OelkeM, De WachterS, DrakeMJ, et al.A practical approach to the management of nocturia. Int J Clin Pract, 2017; 71:e1302–7.
7.
LoprestiAL, DrummondPD, SmithSJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. Am J Mens Health, 2019; 13:155798831983598–5.
8.
ChenYC, ChenYH, PanBS, et al.Functional study of Cordyceps sinensis and cordycepin in male reproduction: A review. J Food Drug Anal, 2017; 25:197–205.
9.
ChrubasikJE, RoufogalisBD, WagnerH, ChrubasikS. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: Urticae radix. Phytomedicine, 2007; 14:568–579.
10.
ErkocM, BesirogluH, OtunctemurA, et al.Metabolic syndrome is associated worsened erectile function in patients undergoing TURP due to benign prostatic hyperplasia. Aging Male, 2018; 23:1–5.
11.
TraishAM, JohansenV. Impact of testosterone deficiency and testosterone therapy on lower urinary tract symptoms in men with metabolic syndrome. World J Mens Health, 2018; 36:199–222.
12.
ChungE, KatzDJ, LoveC. Adult male stress and urge urinary incontinence—A review of pathophysiology and treatment strategies for voiding dysfunction in men. Aust Fam Physician, 2017; 46:661–666.
13.
EspinosaG, EspositoR, KazzaziA, DjavanB. Vitamin D and benign prostatic hyperplasia—A review. Can J Urol, 2013; 20:6820–6825.
14.
NomiyaM, AnderssonKE, YamaguchiO. Chronic bladder ischemia and oxidative stress: New pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol, 2015; 22:40–46.
15.
VidlarA, StudentVJr, VostalovaJ, et al.Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: A double-blind, randomized, placebo-controlled study. World J Urol, 2016; 34:419–424.
16.
BraskyTM, DarkeAK, SongX, et al.Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst, 2013; 105:1132–1141.
17.
AbramsDI. An integrative approach to prostate cancer. J Altern Complement Med, 2018; 24:872–880.
18.
Demark-WahnefriedW, PolascikTJ, GeorgeSL, et al.Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev, 2008; 17:3577–3587.
19.
MessinaM. Soybean isoflavone exposure does not have feminizing effects on men: A critical examination of the clinical evidence. Fertil Steril, 2010; 93:2095–2104.
20.
TabayoyongW, AbouassalyR. Prostate cancer screening and the associated controversy. Surg Clin North Am, 2015; 95:1023–1039.
21.
AndrioleGL, CrawfordED, Grubb RL 3rd, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. J Natl Cancer Inst, 2012; 104:125–132.
22.
HugossonJ, CarlssonS, AusG, et al.Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol, 2010; 11:725–732.
23.
EspinosaG. Thrive, Don't Only Survive: Dr. Geo's Guide to Living Your Best Life Before & After Prostate Cancer. New York: CreateSpace Independent Publishing Platform, 2016.
24.
BartlikB, EspinosaG, MindesJ. Integrative Sexual Health. New York: Oxford University Press, 2018.
